CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated Other Comprehensive Income (Loss) | Series A convertible preferred stock | Series A convertible preferred stock Preferred Stock | Series A convertible preferred stock Accumulated Deficit | Series B perpetual preferred stock | Series B perpetual preferred stock Preferred Stock | Series B perpetual preferred stock Accumulated Deficit |
Balance (in value) at Dec. 31, 2021 | $ 176 | | $ 387.8 | $ (276.8) | | | $ 65 | | | | |
Balance (in shares) at Dec. 31, 2021 | | 62,489,278 | | | | | 650,000 | | | | |
Exercise of options (in value) | 0.8 | | 0.8 | | | | | | | | |
Exercise of options (in shares) | | 91,425 | | | | | | | | | |
Exercise of warrants (in value) | 9.4 | | 9.4 | | | | | | | | |
Exercise of warrants (in shares) | | 817,648 | | | | | | | | | |
Vesting of stock awards (in shares) | | 43,450 | | | | | | | | | |
Series A convertible preferred stock dividend | | | | | | $ (1.2) | | $ (1.2) | | | |
Stock-based compensation expense | 2.2 | | 2.2 | | | | | | | | |
Net Income (Loss) | 13 | | | 13 | | | | | | | |
Balance (in value) at Mar. 31, 2022 | 200.2 | | 400.2 | (265) | | | $ 65 | | | | |
Balance (in shares) at Mar. 31, 2022 | | 63,441,801 | | | | | 650,000 | | | | |
Balance (in value) at Dec. 31, 2021 | 176 | | 387.8 | (276.8) | | | $ 65 | | | | |
Balance (in shares) at Dec. 31, 2021 | | 62,489,278 | | | | | 650,000 | | | | |
Foreign currency translation adjustments | (0.1) | | | | | | | | | | |
Net Income (Loss) | 30.7 | | | | | | | | | | |
Balance (in value) at Jun. 30, 2022 | 218.7 | | 402.3 | (248.5) | $ (0.1) | | $ 65 | | | | |
Balance (in shares) at Jun. 30, 2022 | | 63,504,018 | | | | | 650,000 | | | | |
Balance (in value) at Mar. 31, 2022 | 200.2 | | 400.2 | (265) | | | $ 65 | | | | |
Balance (in shares) at Mar. 31, 2022 | | 63,441,801 | | | | | 650,000 | | | | |
Vesting of stock awards (in value) | (0.2) | | (0.2) | | | | | | | | |
Vesting of stock awards (in shares) | | 62,217 | | | | | | | | | |
Series A convertible preferred stock dividend | | | | | | (1.2) | | (1.2) | | | |
Stock-based compensation expense | 2.3 | | 2.3 | | | | | | | | |
Foreign currency translation adjustments | (0.1) | | | | (0.1) | | | | | | |
Net Income (Loss) | 17.7 | | | 17.7 | | | | | | | |
Balance (in value) at Jun. 30, 2022 | 218.7 | | 402.3 | (248.5) | (0.1) | | $ 65 | | | | |
Balance (in shares) at Jun. 30, 2022 | | 63,504,018 | | | | | 650,000 | | | | |
Balance (in value) at Dec. 31, 2022 | 193 | | 293.1 | (232.3) | (0.4) | | $ 65 | | | $ 67.6 | |
Balance (in shares) at Dec. 31, 2022 | | 45,028,041 | | | | | 650,000 | | | 67,597 | |
Vesting of stock awards (in value) | (0.2) | | (0.2) | | | | | | | | |
Vesting of stock awards (in shares) | | 158,359 | | | | | | | | | |
Series A convertible preferred stock dividend | | | | | | (1.2) | | (1.2) | $ (1.5) | | $ (1.5) |
Stock-based compensation expense | 2.9 | | 2.9 | | | | | | | | |
Foreign currency translation adjustments | (0.1) | | | | (0.1) | | | | | | |
Net Income (Loss) | 0.5 | | | 0.5 | | | | | | | |
Balance (in value) at Mar. 31, 2023 | 193.4 | | 295.8 | (234.5) | (0.5) | | $ 65 | | | $ 67.6 | |
Balance (in shares) at Mar. 31, 2023 | | 45,186,400 | | | | | 650,000 | | | 67,597 | |
Balance (in value) at Dec. 31, 2022 | 193 | | 293.1 | (232.3) | (0.4) | | $ 65 | | | $ 67.6 | |
Balance (in shares) at Dec. 31, 2022 | | 45,028,041 | | | | | 650,000 | | | 67,597 | |
Foreign currency translation adjustments | 0.5 | | | | | | | | | | |
Net Income (Loss) | 6.2 | | | | | | | | | | |
Balance (in value) at Jun. 30, 2023 | 176.5 | | 295.1 | (231.3) | 0.1 | | $ 65 | | | $ 47.6 | |
Balance (in shares) at Jun. 30, 2023 | | 45,650,941 | | | | | 650,000 | | | 47,597 | |
Balance (in value) at Mar. 31, 2023 | 193.4 | | 295.8 | (234.5) | (0.5) | | $ 65 | | | $ 67.6 | |
Balance (in shares) at Mar. 31, 2023 | | 45,186,400 | | | | | 650,000 | | | 67,597 | |
Exercise of options (in shares) | | 4,000 | | | | | | | | | |
Vesting of stock awards (in value) | (2.3) | | (2.3) | | | | | | | | |
Vesting of stock awards (in shares) | | 460,541 | | | | | | | | | |
Series A convertible preferred stock dividend | | | | | | $ (1.2) | | $ (1.2) | (1.3) | | $ (1.3) |
Preferred stock redemption (in shares) | | | | | | | | | | (20,000) | |
Preferred stock redemption (in value) | | | | | | | | | $ (20) | $ (20) | |
Stock-based compensation expense | 1.6 | | 1.6 | | | | | | | | |
Foreign currency translation adjustments | 0.6 | | | | 0.6 | | | | | | |
Net Income (Loss) | 5.7 | | | 5.7 | | | | | | | |
Balance (in value) at Jun. 30, 2023 | $ 176.5 | | $ 295.1 | $ (231.3) | $ 0.1 | | $ 65 | | | $ 47.6 | |
Balance (in shares) at Jun. 30, 2023 | | 45,650,941 | | | | | 650,000 | | | 47,597 | |